Yannick Valogne

534 total citations
13 papers, 424 citations indexed

About

Yannick Valogne is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yannick Valogne has authored 13 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Surgery. Recurrent topics in Yannick Valogne's work include Pluripotent Stem Cells Research (3 papers), Cancer Research and Treatments (2 papers) and CAR-T cell therapy research (2 papers). Yannick Valogne is often cited by papers focused on Pluripotent Stem Cells Research (3 papers), Cancer Research and Treatments (2 papers) and CAR-T cell therapy research (2 papers). Yannick Valogne collaborates with scholars based in France, United States and Japan. Yannick Valogne's co-authors include Alexandre Juillerat, Julien Valton, Philippe Duchâteau, Laurent Poirot, Alan Maréchal, Aymeric Duclert, J Faivre, Christian Bréchot, Didier Samuel and Julie Hervé and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer Research.

In The Last Decade

Yannick Valogne

13 papers receiving 419 citations

Peers

Yannick Valogne
Sai Mun Leong Singapore
Jonathan Lerner United States
Benjamin Philipson United States
Anne M. Miermont United States
Yijun Lu China
Peirong Hu United States
Sarbajeet Nagdas United States
Yannick Valogne
Citations per year, relative to Yannick Valogne Yannick Valogne (= 1×) peers Naoko Utsunomiya

Countries citing papers authored by Yannick Valogne

Since Specialization
Citations

This map shows the geographic impact of Yannick Valogne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yannick Valogne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yannick Valogne more than expected).

Fields of papers citing papers by Yannick Valogne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yannick Valogne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yannick Valogne. The network helps show where Yannick Valogne may publish in the future.

Co-authorship network of co-authors of Yannick Valogne

This figure shows the co-authorship network connecting the top 25 collaborators of Yannick Valogne. A scholar is included among the top collaborators of Yannick Valogne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yannick Valogne. Yannick Valogne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Stillitano, Francesca, Jens Hansen, Chi‐Wing Kong, et al.. (2017). Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells. eLife. 6. 70 indexed citations
2.
Juillerat, Alexandre, Alan Maréchal, Yannick Valogne, et al.. (2017). An oxygen sensitive self-decision making engineered CAR T-cell. Scientific Reports. 7(1). 39833–39833. 183 indexed citations
3.
Féraud, Olivier, Yannick Valogne, Michael W. Melkus, et al.. (2016). Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines. PLoS ONE. 11(3). e0149291–e0149291. 21 indexed citations
4.
Mitjavila‐Garcia, Maria Teresa, Stéphane Flamant, Yannick Valogne, et al.. (2014). Generation of Multipotent Early Lymphoid Progenitors from Human Embryonic Stem Cells. Stem Cells and Development. 23(24). 2983–2995. 11 indexed citations
5.
Guerrieri, Francesca, Silvia Piconese, Valeria Schinzari, et al.. (2013). The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells. Cell Death and Disease. 4(9). e807–e807. 20 indexed citations
6.
Hervé, Julie, Alexandre Dos Santos, Nicolas Moniaux, et al.. (2012). Iodide Transporter NIS Regulates Cancer Cell Motility and Invasiveness by Interacting with the Rho Guanine Nucleotide Exchange Factor LARG. Cancer Research. 72(21). 5505–5515. 39 indexed citations
8.
Sandt, Christophe, Olivier Féraud, Noufϊssa Oudrhiri, et al.. (2012). Identification of Spectral Modifications Occurring during Reprogramming of Somatic Cells. PLoS ONE. 7(4). e30743–e30743. 16 indexed citations
9.
Melkus, Michael W., Annelise Bennaceur‐Griscelli, Yannick Valogne, et al.. (2012). Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell–derived hematopoiesis model. Experimental Hematology. 41(4). 335–345.e3. 6 indexed citations
10.
Hervé, Julie, Nicolas Moniaux, François Faitot, et al.. (2010). 41 THE SODIUM IODIDE SYMPORTER ENHANCES CELL MIGRATION AND INVASION. Journal of Hepatology. 52. S18–S18. 1 indexed citations
11.
Hervé, Julie, António Sá Cunha, Bingkaï Liu, et al.. (2008). Internal Radiotherapy of Liver Cancer with Rat Hepatocarcinoma-Intestine-Pancreas Gene as a Liver Tumor-Specific Promoter. Human Gene Therapy. 19(9). 915–926. 24 indexed citations
12.
Liu, Bingkaï, Julie Hervé, Paulette Bioulac‐Sage, et al.. (2007). Sodium Iodide Symporter Is Expressed at the Preneoplastic Stages of Liver Carcinogenesis and in Human Cholangiocarcinoma. Gastroenterology. 132(4). 1495–1503. 21 indexed citations
13.
Hervé, Julie, António Sá Cunha, M. Longuet, et al.. (2006). 377 Recombinant viral vectors expressing sodium-iodide symporter for hepatocelllular carcinoma radiotherapy. Journal of Hepatology. 44. S143–S144. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026